UPDATE: Dermata Therapeutics Has Received A Notice Of Allowance For A U.S. Patent Titled "COMPOSITIONS FOR THE TREATMENT OF SKIN CONDITIONS"
Share
Dermata Therapeutics, Inc.
DRMA
1.36
+0.74%